Digoxin and its related endogenous factors

SA Jortani, R Valdes, SI Soldin… - Critical reviews in …, 1997 - Taylor & Francis
The digitalis drugs are plant-derived cardenolide compounds used medicinally for several
hundred years. These drugs elicit inotropic and chronotropic effects on the heart, but they …

Analytical performance of a monoclonal digoxin assay with increased specificity on the ACS: 180

JJ Miller, RW Straub Jr, R Valdes Jr - Therapeutic drug monitoring, 1996 - journals.lww.com
Digoxin metabolites cross-react in the Ciba Corning ACS digoxin assay in proportion to their
bioactivity, but have greater (near 100%) cross-reactivity in the Abbott TDx, Baxter Stratus …

Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA …

P Datta, A Dasgupta - Therapeutic drug monitoring, 2004 - journals.lww.com
Endogenous digoxin-like immunoreactive factors (DLIF) cross-react with antidigoxin
antibody and falsely elevate or lower measured serum digoxin concentrations, depending …

Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances

A Dasgupta - Toxicological reviews, 2006 - Springer
Digoxin is a cardioactive drug with a narrow therapeutic range. Therapeutic drug monitoring
is essential in clinical practice for efficacy as well as to avoid digoxin toxicity. Immunoassays …

Effect of antibody specificity on results of selected digoxin immunoassays among various clinical groups

P Datta, L Xu, S Malik, D Landicho, L Ferreri… - Clinical …, 1996 - academic.oup.com
We examined the specificity of three automated digoxin immunoassays (Abbott TDxFLx
Digoxin II assay, Baxter-Dade Stratus II Digoxin assay, and Ciba Corning ACS Digoxin …

Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay

MJ Crossey, A Dasgupta - Therapeutic drug monitoring, 1997 - journals.lww.com
Digoxin-like immunoreactive substance (DLIS) is known to interfere with fluorescence
polarization immunoassay (FPIA)(Digoxin II, Abbott Laboratories) and falsely elevates the …

Effect of digoxin Fab antibodies on five digoxin immunoassays

MR Ujhelyi, DM Cummings, P Green… - Therapeutic Drug …, 1990 - journals.lww.com
Following digoxin Fab antibody (FAB) administration in digitalistoxic patients, total serum
digoxin concentrations (SDCS) become elevated, but do not correlate with pharmacologic …

Cross reactivity of the EMIT digoxin assay with digoxin metabolites, and validation of the method for measurement of urinary digoxin.

L Linday, DE Drayer - Clinical chemistry, 1983 - academic.oup.com
In evaluating the EMIT (Syva Co.) digoxin assay, we found no cross reactivity between
dihydrodigoxin, the major digoxin metabolite, and the EMIT digoxin antibody from two …

Inaccuracies in digoxin measurement

JD Cook, TR Koch, MS Cook, EC Knoblock - Clinical Biochemistry, 1988 - Elsevier
Six commercial digoxin immunoassay kits were evaluated for their accuracy of calibration
and their extent of interference by digoxinlike immunoreactive substance (DLIS). Calibration …

Improved liquid chromatographic/immunoassay of digoxin in serum.

JA Stone, SJ Soldin - Clinical chemistry, 1988 - academic.oup.com
This HPLC/immunoassay procedure measures digoxin in serum with no interference from
digoxin metabolites or digoxin-like factors. We used solid-phase (C18 and Diol) extraction, a …